LDS/Medical Tests/Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis

Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis

Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is the most common autosomal dominant central nervous system neurodegenerative. SCA3 is divided into 3 forms. SCA3 type 1 (MJD Type 1) associated with ataxia, ophthalmoparesis, pyramidal signs, extrapyramidal signs including dystonia and other movement disorders presenting in adolescence. SCA3 type 2 (MJD Type 2) occurs in middle adulthood with ataxia, spasticity, and dystonia. SCA3 type 3 (MJD Type 3) is common after the age of 40 and includes ophthalmoparesis and anterior horn cell disease, i.e. fasciculations, atrophy, and weakness. A Parkinsonian syndrome can also be associated with SCA3.

This disease is caused by CAG repeat expansion mutation in the ATXN3 gene, which is located on chromosome 14q24.3-q32. The diagnosis of SCA3 requires molecular genetic testing to detect an abnormal CAG trinucleotide repeat in ATXN3 gene. The prevalence of MJD is estimated to be 1-2 in 100,000 with significant geographical and ethnic variations.

  • Diagnosis of spinocerebellar ataxia type 3 (SCA3) in patients with cerebellar ataxia
  • As an aid in the prenatal diagnosis of Machado-Joseph disease
  • To detect the carrier of CAG repeat expansion mutation in the ATXN3 gene

Normal:

  • CAG trinucleotide repeats expansion between 13-36

Abnormal:

  • CAG trinucleotide repeats expansion between 68-79

Normal: < 44 CAG trinucleotide repeats expansion

Next generation sequencing, repeat expansion detection by PCR, gel electrophoresis.

Whole blood (EDTA lavender top tube).

Stability

  • Room temperature: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Presymptomatic test (PST), prenatal diagnosis (PND), preimplantation genetic diagnosis (PGD).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login